You are here

  • Home
  • Archive
  • Volume 9, Issue 7
  • Newly developed pseudogout arthritis after therapy with MAGE-A4 directed TCR T cells responded to treatment with tocilizumab

Article metrics

Article menu

Download PDFPDF

XML
Case report
Newly developed pseudogout arthritis after therapy with MAGE-A4 directed TCR T cells responded to treatment with tocilizumab

 

Online download statistics by month:

Online download statistics by month: July 2021 to March 2026

AbstractFullPdf
Jul 2021356359124
Aug 202112312238
Sep 2021999847
Oct 2021767623
Nov 20219810034
Dec 2021767626
Jan 2022606518
Feb 2022434318
Mar 202260619
Apr 2022505218
May 2022707042
Jun 2022778131
Jul 2022636514
Aug 2022666743
Sep 2022616125
Oct 2022737838
Nov 2022646426
Dec 202230294
Jan 202323237
Feb 2023596012
Mar 2023484813
Apr 202328299
May 202329298
Jun 202329297
Jul 2023393917
Aug 202327275
Sep 202332312
Oct 202333338
Nov 202349478
Dec 202330308
Jan 202425266
Feb 2024343412
Mar 2024484865
Apr 2024323212
May 2024353516
Jun 2024494812
Jul 202414815114
Aug 2024959614
Sep 2024495014
Oct 2024535320
Nov 2024989914
Dec 202486909
Jan 2025686832
Feb 2025979716
Mar 2025626126
Apr 202517918121
May 2025676718
Jun 2025292917
Jul 2025110
Aug 2025210
Nov 2025100
Dec 2025300
Mar 2026400
Total323632591020